"Will be interesting to see the fortitude of us long term investors if the FDA comes back tomorrow and says "we need more data" and then says M2M needs a phase 3.
Read More: https://investorshangout.com/post/view?id=582...z6S54cC92i
I hope I am not a Nostradamus, but today's PR may wake up some of the posters who had become a little too fluffy bunny and unicorns. The road to revenue may be bumpy and the FDA is going to treat us like everyone else. Viiv had their HIV app denied on CMC issues. If we miss something(which we did) FDA responds in kind. Guarded optimism is the best approach. For those buying in the 5-10 range gonna be tough to hold strong depending on how emotionally attached to your money you are. My cost basis is 54 cents so easy for me to hang on through covid results.
I wonder if there is a 5 second delay on the CC to bleep out any potential questions from shareholders?
Read More: https://investorshangout.com/post/view?id=582...z6S54cC92i
I hope I am not a Nostradamus, but today's PR may wake up some of the posters who had become a little too fluffy bunny and unicorns. The road to revenue may be bumpy and the FDA is going to treat us like everyone else. Viiv had their HIV app denied on CMC issues. If we miss something(which we did) FDA responds in kind. Guarded optimism is the best approach. For those buying in the 5-10 range gonna be tough to hold strong depending on how emotionally attached to your money you are. My cost basis is 54 cents so easy for me to hang on through covid results.
I wonder if there is a 5 second delay on the CC to bleep out any potential questions from shareholders?
1
